Beta-Agonist Alternatives to Nebulized Albuterol for Treatment of Hyperkalemia

Today’s pearl provides some alternative methods to treat patients with hyperkalemia if nebulized albuterol is not an option.

What route? Which medication? How much?
Continue reading “Beta-Agonist Alternatives to Nebulized Albuterol for Treatment of Hyperkalemia”

Magnesium for Atrial Fibrillation Rate Control in the ED

Today’s pearl is a continuation of Pearl 42: Medication Pearls for Atrial Fibrillation Management in the ED and reviews the role of magnesium for the treatment of atrial fibrillation.

Does magnesium reduce HR? How much and how fast to administer?
Continue reading “Magnesium for Atrial Fibrillation Rate Control in the ED”

Medication Pearls for Atrial Fibrillation Management in the ED

Today’s pearl highlights 5 main points related to the treatment of atrial fibrillation.

Should you give a beta blocker or a calcium channel blocker? What dose should you use?
Continue reading “Medication Pearls for Atrial Fibrillation Management in the ED”

QTc Prolongation and Torsades de Pointes with Droperidol in the Emergency Department

How common is QTc prolongation or Torsades de Pointes (TdP) in ED patients getting droperidol?

Actually quite rare!

In 30,000 patients, TdP occurred once (the patient had multiple risk factors and TdP didn’t reoccur when re-challenged).

Prior data covered in 2015 @aaeminfo position statement.

Use of IV Iodinated Contrast Media in Patients with Preexisting Renal Disease

Today’s pearl reviews some of the literature and recommendations regarding the use of iodinated contrast in patients with kidney disease

Will it cause an acute-on-chronic injury? Is it safe?
Continue reading “Use of IV Iodinated Contrast Media in Patients with Preexisting Renal Disease”

Importance of Boluses with Rate Changes for Opioid & Benzodiazepine Infusions

Today’s pearl provides some advice on how to properly increase sedative rates for intubated patients

Why do boluses matter?
Continue reading “Importance of Boluses with Rate Changes for Opioid & Benzodiazepine Infusions”